An Error Occurred: Forbidden

Oops! An Error Occurred

The server returned a "403 Forbidden".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.
An Error Occurred: Forbidden

Oops! An Error Occurred

The server returned a "403 Forbidden".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.
Børs og finans

Markedet gir tommelen opp til Targovax

Targovax øker antall pasienter i sin siste studie. 

Targovax-sjef Øystein Soug. Foto: Finansavisen

Targovax-sjef Øystein Soug. Foto: Finansavisen

Artikkel av: John Inge Seljehaug
7. februar 2018 - 09.09
An Error Occurred: Forbidden

Oops! An Error Occurred

The server returned a "403 Forbidden".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.

Targovax er ute med en oppdatering på sin forstudie hvor legemiddelselskapet har brukt Oncos-102 i kombinasjon med standard strålebehandling for pasienter med mesoteliom. 

Dette i tillegg til vanlig standard kjemoterapi.

Targovax opplyser at sikkerhetsdataene var meget lovende, og at behandlingen utløste en medfødt immunsrespons hos 3/3 personer.

Selskapet øker derfor antallet pasienter med 24 personer, fra opprinnelig seks i forstudien. 

Aksjen spratt rett opp 10,0 prosent til topp på Oslo Børs, men er nå opp 6,23 prosent til 17,38 kroner. 

An Error Occurred: Forbidden

Oops! An Error Occurred

The server returned a "403 Forbidden".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.
An Error Occurred: Forbidden

Oops! An Error Occurred

The server returned a "403 Forbidden".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.